Exogenous procalcitonin evokes a pro-inflammatory cytokine response

Systemic inflammation and sepsis are associated with elevated procalcitonin (ProCT) levels in the blood. Prior research has shown that ProCT is a biomarker for bacterial infections and sepsis. However, the direct role of ProCT in immune cell function remains unclear. Established knowledge suggests that ProCT may act as a signaling molecule in immune responses. That uncertainty drove investigations into whether ProCT can directly influence polymorphonuclear leukocytes (PMNs) independently of bacterial endotoxins. No prior work had resolved how ProCT affects cytokine production or PMN function. This gap motivated experiments using recombinant ProCT to test its effects on immune responses. The study aimed to clarify ProCT's role in inflammation and PMN activity.

The purpose of the study was to determine if exogenous procalcitonin (ProCT) can directly influence cytokine production and immune cell function. Researchers focused on polymorphonuclear leukocytes (PMNs) and their response to ProCT exposure. The study aimed to test whether ProCT could modulate cytokine levels in whole blood and PMNs. A specific problem addressed was whether ProCT could alter PMN migration and phagocytosis. The motivation stemmed from clinical observations linking ProCT to systemic inflammation. The study sought to isolate ProCT’s effects from those of bacterial endotoxins. Researchers aimed to measure cytokine responses and PMN function after ProCT exposure. The goal was to clarify ProCT’s role in immune activation and sepsis.

The study used recombinant human ProCT (rhProCT) to test its effects on immune responses. Whole blood and isolated polymorphonuclear leukocytes (PMNs) were exposed to varying doses of rhProCT in vitro. Researchers measured cytokine levels using a multiplex suspension bead-array immunoassay. The cytokines tested included IL-6, IL-8, IL-10, IL-13, TNFα, IL-1β, and MIP-1β. PMN migration and phagocytosis were also assessed in response to ProCT exposure. The experimental design included dose-dependent comparisons of cytokine production. Researchers used clinically relevant ProCT concentrations to mimic sepsis conditions. The results were analyzed to determine if ProCT could directly influence immune cell activity.

Exposure to exogenous ProCT led to a dose-dependent increase in IL-6, TNFα, and IL-1β in whole blood. These cytokines are markers of systemic inflammation and immune activation. The cell-free supernatant showed elevated levels after ProCT incubation. PMN migration decreased when pre-incubated with ProCT at sepsis-relevant doses. Phagocytosis of Staphylococcus aureus remained unchanged despite altered migration. Indirect measures of bacterial killing were also unaffected by ProCT exposure. The findings suggest ProCT can modulate cytokine production independently of endotoxins. This response may contribute to the systemic inflammatory response seen in sepsis.

The authors propose that exogenous ProCT can influence cytokine production in whole blood and PMNs. Their findings suggest ProCT may contribute to systemic inflammation in sepsis. The observed decrease in PMN migration supports a role for ProCT in immune modulation. The unchanged phagocytosis and bacterial killing suggest ProCT’s effects are selective. The study traces these conclusions directly to the observed cytokine responses. No prior work had resolved ProCT’s direct effects on immune cells. The results align with clinical observations linking ProCT to sepsis severity. The authors suggest these findings may inform future research on ProCT’s role in sepsis.